Showing results (851-860 of 1,196) with videos related to
Sort By:
Pageof 120
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitroH Tilg, L Shapiro, E Vannier, et al.Advances in Alcohol & Substance Abuse|January 1, 1990
Reactions of methadone patients to HIV antibody testingS Magura, J L Shapiro, J I Grossman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanomaSandra R Reynolds, Anne Zeleniuch-Jacquotte, Richard L Shapiro, et al.Journal of Clinical Psychology|March 20, 2001
Quality of life and breast cancer: relationship to psychosocial variablesS L Shapiro, A M Lopez, G E Schwartz, et al.Cornea|April 18, 2013
High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesisBrett L Shapiro, Dennis E Cortés, Eric K Chin, et al.The American Journal of Pathology|January 1, 1997
Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid folliclesR L Shapiro, J G Duquette, I Nunes, et al.AIDS (London, England)|January 11, 2000
A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjectsJ B Angel, M A Jacobson, P R Skolnik, et al.The Breast Journal|May 12, 2001
Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control studyA J Janov, M Tulecke, A O'Neill, et al.Cancer|August 15, 1991
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimensC L Shapiro, B Y Yeap, J Godleski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Bicalutamide for advanced prostate cancer: the natural versus treated history of diseaseH I Scher, C Liebertz, W K Kelly, et al.Pageof 120